Literature DB >> 839122

Radioimmunoassay for serum transcobalamin II.

T A Morelli, C R Savage, J A Begley, C A Hall.   

Abstract

A radioimmune assay for transcobalamin II (TC II) was devised from the following: (1) TC II-57Co B12 precipitated from normal serum with (NH4)2SO4 as the labeled ligand; (2) the TC II of whole serum as the standard source of TC II; (3) rabbit anti-pure TC II as the binding agent; (4) separation of the bound and free TC II-B12 by precipitation of the antibody bound with polyethylene glycol. The assay was responsive to either TC II or TC II-B12 and to TC II either pure or in crude preparations. It was not responsive to R-type binders of B12. The median TC II of 10 normal sera was 890 pg. per milliliter and of 10 sera from 10 random hospital patients was 1,010 pg. per milliliter. There was no measurable TC II in the serum of a child with congenital absence of TC II and the assay measured levels greater than 5,000 pg. per milliliter in abnormalities of TC II metabolism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 839122

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

Review 1.  Transcobalamin II deficiency: case report and review of the literature.

Authors:  Y Kaikov; L D Wadsworth; C A Hall; P C Rogers
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

2.  Congenital deficiency of human R-type binding proteins of cobalamin.

Authors:  C A Hall; J A Begley
Journal:  Am J Hum Genet       Date:  1977-11       Impact factor: 11.025

3.  Limitations of protein-coated charcoal in the separation of free from bound vitamin B12 in serum.

Authors:  E Jacob; K T Wong
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

Review 4.  Genetic patterns of transcobalamin II and the relationships with congenital defects.

Authors:  M Fràter-Schröder
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

5.  Megaloblastic anemia as a result of an abnormal transcobalamin II (Cardeza).

Authors:  F I Haurani; C A Hall; R Rubin
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

6.  Granulocyte dysfunction in transcobalamin II deficiency responding to leucovorin or hydroxocobalamin-plasma transfusion.

Authors:  R Seger; M Fràter-Schröder; W H Hitzig; A Wildfeuer; J C Linnell
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.